A Phase 2, Open Label, Multicenter, Randomized Trial Comparing Tivozanib in Combination With mFOLFOX6 to Bevacizumab in Combination With mFOLFOX6, In Stage IV Metastatic Colorectal Cancer (mCRC) Subjects
Latest Information Update: 07 Apr 2022
At a glance
- Drugs Tivozanib (Primary) ; Bevacizumab; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Biomarker; Therapeutic Use
- Acronyms BATON-CRC
- Sponsors Astellas Pharma
- 06 Apr 2022 This trial has been completed in Netherland (End Date: 07 Jan 2015), according to European Clinical Trials Database record.
- 11 Jul 2016 Results (n=265) published in the Clinical cancer research: an official journal of the American Association for Cancer Research
- 04 Jul 2015 Results presented at the 17th World Congress on Gastrointestinal Cancer.